India  

United States: § 112(a) Is A Priority In Decision To Institute IPR; Did Not Work To Say Petitioner Should Have Filed A PGR - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq Thursday, 24 August 2023
Petitioner Dr. Reddy's Laboratories challenged the patentability of several claims of U.S. Patent No. 11,110,087 ("the '087 patent") on 35 U.S.C. § 102 anticipation grounds. IPR2023-00052, Paper 7 at *4.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

United States: USPTO Pro Bono Initiatives And Resources (Podcast) - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

In this podcast, Kevin Rodkey and Derrick Brent highlight the remarkable pro bono initiatives and resources offered by the United States Patent and Trademark...
Mondaq

United States: USPTO's Updates On PTA Practice And "Safe Harbor" Of § 1.704(d) - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

On June 15, 2023, the USPTO issued a Final Rule on the Standardization of the Patent Term Adjustment Statement Regarding Information Disclosure Statements.
Mondaq

United States: Prosecution Pointer 391 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

How does a stakeholder get notified of an eGrant? Issue Notifications will be available electronically via Patent Center after the payment of the issue fee....
Mondaq